Pidus Tablet

About Pidus 15 mg Tablet

Pidus 15 mg Tablet is made by The ACME Laboratories Ltd. and contains the generic pioglitazone, a thiazolidinedione used as an adjunct to diet and exercise for adults with type II diabetes, either alone or alongside other diabetes medicines.

There are 12 brands of Pioglitazone listed in Bangladesh. 7 of them have a lower unit price than Pidus. The lowest listed price is Pioglinet 15 mg Tablet at ৳ 1 per unit.

What is Pidus 15 mg Tablet?

Pidus 15 mg Tablet from The ACME Laboratories Ltd. contains pioglitazone, a thiazolidinedione group oral antidiabetic medicine. It is used as an adjunct to diet and exercise to improve blood sugar control in people with type II diabetes. It works by reducing insulin resistance in the body and the liver, and it needs the presence of insulin to act. It can be used alone or in combination with other diabetes medicines such as a sulphonylurea, metformin or insulin when diet, exercise and a single agent do not control blood sugar well. The doctor decides whether it suits a particular person.

Uses of Pidus

Pidus 15 mg Tablet is used as an add-on to diet and exercise to improve blood sugar control in type II diabetes. It may be prescribed alone, or together with a sulphonylurea, metformin or insulin when diet, exercise and one medicine do not give adequate control. Because it works only when insulin is present, it is not meant for type 1 diabetes or for diabetic ketoacidosis. Your doctor will decide if it is appropriate for your situation.

How to use Pidus

Pidus 15 mg Tablet is taken by mouth. The doctor decides the dose and how long the course should continue; do not change the amount or stop it on your own. The tablet can generally be taken without regard to meals. If you also use other diabetes medicines, follow the instructions your doctor gives for each one. Ask your doctor or pharmacist if you are unsure how to take it, and tell them about any other medicines you use.

Side effects of Pidus

In placebo-controlled trials of pioglitazone, the more commonly reported events included upper respiratory tract infection, headache, sinusitis, muscle pain, tooth disorder and sore throat. Not everyone gets these, and this is not a complete list. If you notice a side effect that bothers you, or if you are worried about any symptom, speak to your doctor or pharmacist. Seek medical help if a symptom is severe or does not settle.

Safety and precautions

Pidus 15 mg Tablet is not for people with a known hypersensitivity to pioglitazone or any of its ingredients. It should not be used in type 1 diabetes or for diabetic ketoacidosis. Use with caution when it is combined with other antidiabetic therapy, and in hepatic insufficiency; liver enzymes should be monitored regularly. There are no adequate and well-controlled studies in pregnant women, so it should be used in pregnancy only if the potential benefit justifies the potential risk to the foetus. It is not known whether it passes into human milk, and it should not be given to a breastfeeding woman. Ask your doctor before starting it if you are pregnant, breastfeeding, or have liver problems.

Frequently asked questions

What is the price of Pidus 15 mg Tablet?

The listed price is ৳ 8.07.

How should Pidus 15 mg Tablet be taken?

It is taken by mouth. The doctor decides the dose and how long you should take it, so follow their instructions and do not change the amount yourself. It can generally be taken without regard to meals. Ask your doctor or pharmacist if anything is unclear.

Who should avoid Pidus 15 mg Tablet or ask the doctor first?

Do not use it if you are hypersensitive to pioglitazone or any ingredient. It is not for type 1 diabetes or diabetic ketoacidosis. Ask your doctor first if you are pregnant, breastfeeding, have liver problems, or use other diabetes medicines, as caution and monitoring may be needed.

What side effects should I watch for, and when should I call the doctor?

Reported events in trials included upper respiratory tract infection, headache, sinusitis, muscle pain, tooth disorder and sore throat. This is not a complete list. If any symptom is severe, does not settle, or worries you, contact your doctor or pharmacist for advice.

Indications

Pioglitazone is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Pioglitazone is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

Pharmacology

Pioglitazone is a preparation of Pioglitazone which is a member of the newest class of oral antidiabetic agent called thiazolidinediones. It depends on the presence of Insulin for its mechanism of action. Pioglitazone decreases Insulin resistance in the periphery and in the liver, resulting in increased Insulin dependent glucose disposal and decreased hepatic glucose output. It also improves abnormality in lipid metabolism by activating peroxisome proliferator activated receptor gamma (PPAR-γ).

Dosage & Administration

Pioglitazone can be taken once daily without regard to meals. The management of antidiabetic therapy should be individualized. Pioglitazone monotherapy may be initiated at 15 mg or 30 mg once daily dosages in patients not adequately controlled with diet and exercise alone. For patients who respond inadequately to the initial dose of Pioglitazone, the dose can be increased up to 45 mg once daily. For patients not responding adequately to monotherapy, combination therapy should be considered.

Maximum recommended daily dose of Pioglitazone should not exceed 45 mg since doses higher than 45 mg have not been studied in placebo controlled clinical studies. Besides, no placebo controlled clinical studies of more than 30 mg once daily have been conducted in combination therapy.

Interaction

Administration of thiazolidinediones with an oral contraceptive containing ethinyl oestradiol and norethindrone reduces the plasma concentration of both hormones by approximately 30% which could result in loss of contraception.

Contraindications

Pioglitazone is contraindicated in patients with known hypersensitivity to any of its components.

Side Effects

The overall incidence and types of adverse events reported in placebo controlled clinical trials of Pioglitazone monotherapy at doses of 7.5 mg, 15 mg, 30 mg or 45 mg once daily are upper respiratory tract infection (13.2%), headache (9.1%), sinusitis (6.3%), myalgia (5.4%), tooth disorder (5.3%), and pharyngitis (5.1%).

Pregnancy & Lactation

Pregnancy: There are no adequate and well controlled studies in pregnant women. Pioglitazone should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus.

Lactation: It is not known whether Pioglitazone is secreted in human milk. As many drugs are excreted in human milk, it should not be administered to a lactating women.

Precautions & Warnings

Pioglitazone exerts its antihyperglycaemic effect only in the presence of Insulin. Therefore, it should not be used in Type 1 diabetes or for the treatment of diabetic ketoacidosis. Pioglitazone should be used with caution in case of combination antidiabetic therapy and hepatic insufficiency. Liver enzyme should be monitored regularly.

Alternative brands of Pioglitazone

Other brands with the same generic name, cheapest first.

Tos Tablet

15 mg

Pioglitazone

Square Pharmaceuticals PLC.

৳ 8.06 per unit

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.